Skip to main navigation Skip to search Skip to main content

Limitations to the use of bromelain-based enzymatic debridement (NexoBrid®) for treating diabetic foot burns: a case series of disappointing results

Research output: Contribution to journalArticlepeer-review

Original languageUndefined
JournalScars, Burns & Healing
DOIs
StatePublished - Jan 2018

Cite this